Renal Anemia: Conflicts and Controversies / Edition 1

Hardcover (Print)
Buy New
Buy New from BN.com
$76.49
(Save 15%)
Used and New from Other Sellers
Used and New from Other Sellers
from $65.45
Usually ships in 1-2 business days
(Save 27%)
Other sellers (Hardcover)
  • All (8) from $65.45   
  • New (3) from $75.84   
  • Used (5) from $65.45   

More About This Textbook

Overview

Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hemarit? Why have clinicians and nephrologists permitted health insurance companies and the government to decide when anemia therapy should begin in persons with progressive kidney failure? Is iron the only variable that can be manipulated to maximize response to recombinant erythropoietin? Are we using too much intravenous iron in kidney failure patients, and is oral iron supplementation worthless in sustaining iron stores during long-term erythropoietin treatment? When does left ventricular hypertrophy begin to emerge in patients with progressive renal disease and is there convincing evidence that anemia is a significant cause of LVH in this setting? Is darbepoetin alfa, a new novel, long-acting erythropoietin, really superior to recombinant erythropoietin? This book is a compilation of proceedings from a conference in Brooklyn convened to address these and other controversial and unresolved issues in renal anemia management.

Read More Show Less

Product Details

  • ISBN-13: 9781402006784
  • Publisher: Springer-Verlag New York, LLC
  • Publication date: 7/31/2002
  • Edition description: 2002
  • Edition number: 1
  • Pages: 160
  • Product dimensions: 0.50 (w) x 6.14 (h) x 9.21 (d)

Table of Contents

Dedication
Introduction to the Conference
Conference Participants
1 Correcting anemia slows renal disease progression 1
2 Does treatment with EPO improve RBC survival? 9
3 Has the best route of administration for epoetin been established? 15
4 Is renal anemia management determined by science or reimbursement regulations? 29
5 When does anemia impact the heart in chronic kidney disease? 37
6 Improvements in anemia management with darbepoetin alfa, a new erythropoiesis stimulating protein 49
7 Normalizing hematocrit in renal failure: dangerous or desirable? 65
8 Do race, gender or mode of dialysis modulate erythropoietin response? 81
9 Are uremic inhibitors of erythropoiesis clinically relevant? 89
10 Do ACE inhibitors limit response to EPO and should EPO be continued in patients with sepsis or fever? 99
11 Is secondary hyperparathyroidism a significant cause of renal anemia? 107
12 Is long-term intravenous iron therapy risky? 115
13 Anemia and erythropoietin therapy in kidney transplant recipients: where are the data? 123
14 Intravenous iron treatment: a comparison of available drugs 129
Epilogue 139
Index 141
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Review Guidelines
Add Recommendations
Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously
    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)